Cardiovascular Health of Older Adults and Resveratrol (CORE)

NCT02909699 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2018-11-29

No results posted yet for this study

Summary

This study will investigate how resveratrol (phenol present in red grapes, wine and peanuts) can improve heart muscle function and ability of arteries to dilate in response to an increase in blood flow in adults 65 years of age and older. Additionally, investigators will look at how resveratrol can improve functioning of cells (cellular house-keeping) which can be related to cardiovascular function.

Conditions

  • Aging

Interventions

OTHER

Observation

In this trial, cardiovascular function will be measured without drug administration. The drug will be administered within the main trial.

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Robert T Mankowski, Ph.D. · University of Florida

Eligibility

Min Age
65 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02909699 on ClinicalTrials.gov